VJOncology is committed to improving our service to you

ASCO 2019 | Molecular imaging for prostate cancer salvage radiotherapy planning

VJOncology is committed to improving our service to you

Jeremie Calais

Here, Jeremie Calais, MD, from the University of California, Los Angeles, CA, discusses results from a Phase III study (NCT03582774) looking at 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning (PSMA-SRT). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter